National Institutes of Health Clinical Center (CC): Liver Neoplasms trials

The registry lists 14 Liver Neoplasms studies with National Institutes of Health Clinical Center (CC) as lead sponsor. 0 are open to participants now and 3 have results posted.

Early Phase 1 1Phase 1 8Phase 2 4No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• LC Bead LUMI Radio-Opaque Embolic Beads to Detect and Characterize the Vascularity of Hepatic TumorsTerminatedNCT02649868Not applicableResults posted
• Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After ChemoembolizationCompletedNCT02471313Phase 2Results posted
• Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver CancerTerminatedNCT00019604Phase 2Results posted
• Study of New Software Used During AblationsCompletedNCT01906021Not applicable
• Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic NeoplasmsTerminatedNCT01862718Phase 1
• A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue BiopsyCompletedNCT01218854Phase 1
• Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
• Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
• Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver TumorsCompletedNCT00093444Phase 1
• ABT-751 in Treating Young Patients With Refractory Solid TumorsCompletedNCT00036959Phase 1
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyCompletedNCT00030108Phase 1
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesCompletedNCT00019786Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasCompletedNCT00019513Phase 1